(Q39530127)

12 September 2017

title

Serum interleukin-33 levels in patients with gastric cancer (English)

1 reference

12 September 2017

0 references

Pinghu Sun

1

1 reference

12 September 2017

Qiwen Ben

2

1 reference

12 September 2017

Shuiping Tu

3

1 reference

12 September 2017

Wenjie Dong

4

1 reference

12 September 2017

Xiaoguang Qi

5

1 reference

12 September 2017

Yunlin Wu

6

1 reference

12 September 2017

publication date

4 June 2011

1 reference

Digestive Diseases and Sciences

12 September 2017

published in

1 reference

12 September 2017

volume

56

1 reference

12 September 2017

issue

12

1 reference

12 September 2017

page(s)

3596-3601

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-011-1760-5

12 September 2017

exact match

0 references

cites work

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

The epidemiology of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Increased interleukin-10 serum levels in patients with solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Diagnostic role of serum interleukin-18 in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Enhanced IL-18 expression in common skin tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Nuclear expression of interleukin-33 in pancreatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

The IL-33/ST2 pathway: therapeutic target and novel biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

T1/ST2--an IL-1 receptor-like modulator of immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Cloning of a putative ligand for the T1/ST2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

IL-33 can promote survival, adhesion and cytokine production in human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Nuclear factor-kappaB and tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1760-5

Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix

21 January 2018

1 reference

12 December 2020

IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers

1 reference

12 December 2020

Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.

1 reference

12 December 2020

Glycolysis links p53 function with NF-κB signaling: Impact on cancer and aging process

1 reference

12 December 2020

Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies

1 reference

12 December 2020

Importance of serum IL-18 and RANTES as markers for breast carcinoma progression

1 reference

12 December 2020

Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma

1 reference

12 December 2020

Interleukin-6 activity in urine and serum in patients with bladder carcinoma

1 reference

12 December 2020

Serum interleukin-6 and -10 levels in patients with gastric cancer

1 reference

12 December 2020

Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: preliminary considerations

1 reference

12 December 2020

Glycolysis links p53 function with NF-kappaB signaling: impact on cancer and aging process

1 reference

12 December 2020

10.1007/S10620-011-1760-5

Identifiers

DOI

1 reference

12 September 2017

1 reference